Literature DB >> 9931097

Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells.

M Horiuchi1, H Yamada, M Akishita, M Ito, K Tamura, V J Dzau.   

Abstract

-Apoptosis has been reported to play a pivotal role in vascular remodeling. However, cellular mechanisms of apoptosis in vascular smooth muscle cells (VSMCs) have not been well defined. In this study, we focused on interleukin-1beta-converting enzyme (ICE), a key protease in the induction of apoptosis in lymphocytes and fibroblasts. We observed an increase in ICE mRNA expression in rat aortic VSMCs after serum depletion, with a peak at 12 hours and then a gradual decline. This was associated with DNA fragmentation, a hallmark of apoptosis and morphological changes of apoptosis. Treatment of these VSMCs with the ICE inhibitor N-(N-acetyl-tyrosinyl-valinyl-alaninyl)-3-amino-4-oxob utanoic acid (YVAD-CHO) attenuated DNA fragmentation. The increased ICE mRNA expression was preceded by an increase in the mRNA expression of interferon regulatory factor (IRF)-1, peaking at 6 hours after serum removal, and a rapid but transient decrease in IRF-2 mRNA expression, reaching a nadir at 3 hours after serum depletion. To demonstrate that these reciprocal changes in IRF-1 and IRF-2 regulated ICE expression and induced apoptosis, we transfected antisense oligonucleotides for IRF-1 and IRF-2 into VSMCs and examined ICE mRNA expression and apoptotic changes. IRF-1 antisense pretreatment attenuated the increase in ICE expression and reduced apoptotic changes, whereas IRF-2 antisense treatment increased ICE mRNA expression and enhanced apoptotic changes. Taken together, our results suggest that serum growth factor depletion in VSMCs upregulates IRF-1 and downregulates IRF-2, thereby increasing ICE expression and inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931097     DOI: 10.1161/01.hyp.33.1.162

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

Authors:  J Michelle Kahlenberg; Seth G Thacker; Celine C Berthier; Clemens D Cohen; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-11-04       Impact factor: 5.422

2.  Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.

Authors:  K M Detjen; K Farwig; M Welzel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

3.  T-lymphocytes mediate left ventricular fibrillar collagen cross-linking and diastolic dysfunction in mice.

Authors:  Qianli Yu; Randy Vazquez; Sherma Zabadi; Ronald R Watson; Douglas F Larson
Journal:  Matrix Biol       Date:  2010-06-25       Impact factor: 11.583

4.  Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome.

Authors:  Zhaoqing Yang; Dmitry Gagarin; Georges St Laurent; Neil Hammell; Ian Toma; Chien-An Hu; Ayaka Iwasa; Timothy A McCaffrey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-05-14       Impact factor: 8.311

5.  Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells.

Authors:  Ming-ming Ni; Tao Xu; Ya-rui Wang; Ying-hua He; Qun Zhou; Cheng Huang; Xiao-ming Meng; Jun Li
Journal:  J Physiol Biochem       Date:  2015-11-26       Impact factor: 4.158

6.  Up-Regulation of Interferon Regulatory Factor 3 Involves in Neuronal Apoptosis After Intracerebral Hemorrhage in Adult Rats.

Authors:  Xuelei Tao; Lili Xie; Chengwei Duan; Shirong Dai; Jianbing Ren; Yaohua Yan; Jianhong Shen; Hongjian Lu; Jianbin Ge
Journal:  Neurochem Res       Date:  2016-07-22       Impact factor: 3.996

7.  IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium.

Authors:  Kai Peng; Xing Fan; Qiannan Li; Yiying Wang; Xiaolin Chen; Pingxi Xiao; Anthony G Passerini; Scott I Simon; ChongXiu Sun
Journal:  J Mol Cell Cardiol       Date:  2020-02-19       Impact factor: 5.000

8.  A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.

Authors:  Michael Höpfner; Andreas P Sutter; Alexander Huether; Gudrun Ahnert-Hilger; Hans Scherübl
Journal:  BMC Cancer       Date:  2004-05-21       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.